$ARE

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE): Results of Operations and Financial Condition

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2026 Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2026 Table of Contents June 30, 2026 COMPANY HIGHLIGHTS Page Page Alexandria's Mission and Cluster Model ..............................................

Original reporting
Published Aug 3, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ARE
Neutral
low confidence
Mentioned
$ARE
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARENeutralLow
01

Why it matters

The attached materials are designed to update investors on financial results, guidance, balance sheet and credit metrics, and operating performance (occupancy, leasing, construction pipeline). Those inputs typically drive REIT valuation and rate/credit sensitivity trades.

02

Market read

This is a company-specific earnings disclosure that can move ARE via guidance and operating/credit metrics, with the next catalyst being the Aug 4 earnings call.

03

What to watch

Traders will likely focus on guidance details, same-property performance, leasing spreads, contractual expirations, and key credit metrics, none of which are actually shown in the provided text.

Relevance 7/10Novelty 3/10Timing: Filed Aug 3, 2026, ahead of the Aug 4, 2026 2:00 p.m. ET earnings call.
alphai · Earnings readARE · Second Quarter Ended June 30, 2026 · ended June 30, 2026

Alexandria reported selected balance-sheet, capital-source, and operating highlights for the second quarter ended June 30, 2026, but the provided filing excerpt does not include the earnings press release financial-results pages.

Mixed quarter

The excerpt presents significant liquidity, long debt duration, and progress on dispositions, while also showing a BBB+ Negative credit-rating outlook and a stated need to execute additional capital sources to support leverage targets.

Revenue
80%

Key metrics

as reported
MetricValueq/qy/y
Alexandria’s Megacampus™ platform as a percentage of annual rental revenueother80%
Significant liquidityother$3.6B
Percentage of fixed-rate debt since 2022other95.7%
Remaining debt termother9.7 years
Debt interest rateother4.08%
Completed dispositions as of August 3, 2026other$170.4 million
Share of pending dispositions and sales of partial interests subject to non-refundable deposits, signed letters of intent, or purchase and sale agreement negotiations as of August 3, 2026other$1.16 billion

4Q26 annualized guidance outlook

  • NoteNet debt and preferred stock to adjusted EBITDA: 5.6x to 6.2x
  • NoteFixed-charge coverage ratio: 3.6x to 4.1x
  • Note2026 sources of capital: $2.9B guidance midpoint

What drove it

  • Alexandria’s Megacampus™ platform represents 80% of annual rental revenue.
  • A new 426,927 RSF facility for Bristol Myers Squibb was delivered in June 2026 under a 15-year lease.
  • The company stated it is focusing on steadily improving occupancy and increasing NOI through leasing to all sectors of its tenant base.
  • The company stated it is reducing capital spend and funding needs while prioritizing capital necessary to lease space.
  • The company stated it does not anticipate the issuance of any common equity during the year ending December 31, 2026.

Concerns

  • The S&P credit rating was BBB+ Negative.
  • The company stated that dispositions, sales of partial interests, and other capital sources are intended to support achievement of leverage-ratio targets.
  • The provided excerpt does not include the financial-results pages needed to assess reported revenue, earnings, FFO, cash flow, occupancy, leasing activity, or same-property performance.

What to watch

  • Execution against annualized 4Q26 net debt and preferred stock to adjusted EBITDA guidance of 5.6x to 6.2x.
  • Execution against annualized 4Q26 fixed-charge coverage ratio guidance of 3.6x to 4.1x.
  • Completion of pending dispositions and sales of partial interests aggregating $1.16 billion as of August 3, 2026.
  • Occupancy and NOI improvement from leasing activity.
  • Progress toward the $2.9B guidance midpoint for 2026 sources of capital.

Balance sheet and cash flow

  • Significant liquidity: $3.6B
  • Percentage of fixed-rate debt since 2022: 95.7%
  • Remaining debt term: 9.7 years
  • Debt interest rate: 4.08%
  • Credit ratings: BBB+ Negative; Baa2 Stable
  • Completed dispositions as of August 3, 2026 aggregated $170.4 million.
  • Our share of pending dispositions and sales of partial interests subject to non-refundable deposits, signed letters of intent, or purchase and sale agreement negotiations aggregated $1.16 billion.
  • Pro forma for the amended and restated unsecured senior line of credit, weighted-average remaining debt term would have been 10.0 years.

Analysis

The provided excerpt does not contain the earnings press release pages with the company’s quarterly income statement, FFO results, revenue, net income, EPS, or cash-flow disclosures. It does identify the reporting period as the second quarter ended June 30, 2026 and provides selected operating and balance-sheet highlights. Consequently, the reported period cannot be evaluated on earnings growth, profitability, or cash-flow performance from the supplied text.

The operating material emphasizes the concentration of Alexandria’s platform in megacampuses, which represented 80% of annual rental revenue as of June 30, 2026. The company also delivered a 426,927 RSF R&D hub for Bristol Myers Squibb in June 2026 under a 15-year lease. Management’s stated operating priorities are to improve occupancy, increase NOI, and lease space across its tenant base, while reducing capital spend and funding needs.

Balance-sheet disclosures in the excerpt show $3.6B of significant liquidity, a 9.7-year remaining debt term, and a 4.08% debt interest rate. The reported percentage of fixed-rate debt since 2022 was 95.7%. The company’s credit ratings were shown as BBB+ Negative and Baa2 Stable, making the negative S&P outlook an important disclosed counterpoint to the liquidity and debt-maturity profile.

Capital sourcing is central to the stated plan. As of August 3, 2026, completed dispositions aggregated $170.4 million, while the company’s share of pending dispositions and sales of partial interests aggregated $1.16 billion. Alexandria stated that it did not anticipate issuing common equity during the year ending December 31, 2026, and presented a $2.9B guidance midpoint for 2026 sources of capital.

The forward balance-sheet targets shown in the excerpt are annualized 4Q26 net debt and preferred stock to adjusted EBITDA of 5.6x to 6.2x and fixed-charge coverage of 3.6x to 4.1x. Investors should focus on execution of pending capital transactions, progress in occupancy and NOI, and delivery against these leverage and coverage targets. No previous outlook was supplied, so no comparison of reported results with prior guidance is available.

Not in the filing

stated, not guessed
  • Total revenue and revenue comparisons
  • Segment revenue and segment comparisons
  • GAAP gross margin
  • GAAP operating income
  • GAAP net income
  • GAAP EPS
  • Non-GAAP earnings measures, including FFO and FFO per share
  • Operating cash flow
  • Free cash flow
  • Dividend declaration or payment
  • Share repurchases
  • Cash balance
  • Total debt balance
  • Quarter-end occupancy
  • Leasing activity metrics
  • Same-property performance metrics
  • Full 2026 guidance ranges and all guidance assumptions
  • Prior-period guidance for comparison
  • Named executive earnings commentary or attributable executive quotes
  • Full financial-results pages, consolidated statements of operations, balance sheets, and FFO reconciliation referenced in the table of contents

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

The filing is an SEC Form 8-K, Item 2.02, attaching an earnings press release supplement for Alexandria Real Estate Equities’ second quarter ended June 30, 2026.

Company-level read

Ticker impact

$ARENeutralLow confidence
Context

ARE filed an 8-K with its 2Q26 results of operations and financial condition, plus guidance and operating metrics in the attached exhibit.

Expected impact

Likely modest-to-moderate volatility around the earnings release and the Aug 4, 2026 conference call, depending on guidance and occupancy/NOI trends.

Evidence & confidence

The provided scrape includes the filing structure and qualitative highlights but does not include the actual numeric results, guidance figures, or key credit metrics needed to forecast direction or magnitude.

Market effects

Life-science REIT demand and leasing momentum are reinforced by the company’s disclosed delivered R&D hub and long-term lease, but sector-wide read-through is limited without broader data.

No specific regional macro or market-wide data is provided in the scrape beyond company-level property/cluster framing.

Minimal, as the disclosure is company-specific and no cross-border financing or global regulatory items are included.

Counterpoint

Qualitative highlights (e.g., delivered facility, long-term lease) may not offset weaker occupancy, higher capex, or less favorable guidance if those are present in the missing numeric tables.

Key entities

  • Alexandria Real Estate Equities, Inc.

    Subject of the 8-K, reporting 2Q26 results and financial condition, with guidance and operating metrics in the exhibit.

  • Bristol Myers Squibb

    Named as the tenant for a delivered 426,927 RSF R&D facility under a 15-year lease referenced in the exhibit highlights.

Every ARE earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$AREMedAI 8/10

Does Alexandria Real Estate Equities' (ARE) $1 Billion Subordinated Note Deal Reframe Its Risk-Reward Profile?

Alexandria Real Estate Equities (ARE) completed a $1B subordinated, unsecured note offering due 2057, with a variable coupon and institutional support. The deal adds long-term funding but doesn't alter near-term risks like vacancies and capital markets uncertainty. ARE projects $2.7B revenue and $479.3M earnings by 2029, with analysts' estimates varying slightly.

$AREMed

Alexandria Real Estate Sets 7.25% Interest Through Feb. 15, 2032

Alexandria Real Estate Equities (NYSE: ARE) priced a $1.0 billion public offering of 7.250% Series A fixed-to-fixed reset rate junior subordinated notes due 2057 at 100% of principal. Interest is 7.250% until Feb. 15, 2032, then resets to the 5-year U.S. Treasury plus 2.889%, with a 7.250% floor. Closing expected around Aug. 21, 2026; proceeds for general corporate purposes.

$AREMedAI 8/10

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $1,000,000,000 of Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057

Alexandria Real Estate Equities (NYSE: ARE) priced a $1.0 billion public offering of 7.250% Series A fixed-to-fixed reset rate junior subordinated notes due 2057. Notes were priced at par and pay 7.250% until Feb. 15, 2032, then reset to the 5-year Treasury plus 2.889% with a 7.250% floor. Proceeds will fund general corporate purposes. Closing expected Aug. 21, 2026.